Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $203.03 USD
Change Today -7.39 / -3.51%
Volume 1.8M
VRX On Other Exchanges
Symbol
Exchange
Toronto
Frankfurt
As of 1:38 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - valeant pharmaceuticals inte (VRX)

NameBoard RelationshipsTitleAge
J. Michael Pearson 30 RelationshipsChairman and Chief Executive Officer55
Howard Bradley Schiller 143 RelationshipsChief Financial Officer, Executive Vice President and Director52
Pavel Mirovsky No RelationshipsPresident of Valeant Europe and General Manager of Valeant Europe63
Robert Roswell Chai-Onn 12 RelationshipsChief Legal Officer, Executive Vice President, Head of Corporate & Business Development and General Counsel44
Ari S. Kellen No RelationshipsExecutive Vice President and Company Group Chairman51

Board Members - valeant pharmaceuticals inte (VRX)

NameBoard RelationshipsPrimary CompanyAge
J. Michael Pearson 30 RelationshipsValeant Pharmaceuticals International, Inc.55
Howard Bradley Schiller 143 RelationshipsValeant Pharmaceuticals International, Inc.52
Robert N. Power 17 RelationshipsValeant Pharmaceuticals International, Inc.57
H. Christian Fibiger Ph.D.28 RelationshipsMedGenesis Therapeutix Inc.71
Norma Ann Provencio 42 RelationshipsValeant Pharmaceuticals International, Inc.57

Executive Committees* - valeant pharmaceuticals inte (VRX)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeNorma Ann Provencio 42 Relationships3 Executives
Compensation CommitteeRonald Harold Farmer 54 Relationships5 Executives
Nominating CommitteeRobert N. Power 17 Relationships4 Executives
Corporate Governance CommitteeRobert N. Power 17 Relationships4 Executives
Advisory BoardH. Christian Fibiger Ph.D. 28 Relationships7 Executives
View VRX Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRX:US $202.69 USD -7.73

VRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Astellas Pharma Inc ¥1,934 JPY -14.50
Mylan NV $71.94 USD -4.12
Perrigo Co PLC $190.51 USD -2.38
Sun Pharmaceutical Industries Ltd 926.40 INR -21.00
Teva Pharmaceutical Industries Ltd $62.16 USD -2.25
View Industry Companies
 

Industry Analysis

VRX

Industry Average

Valuation VRX Industry Range
Price/Earnings 78.6x
Price/Sales 8.5x
Price/Book 13.2x
Price/Cash Flow 30.1x
TEV/Sales 6.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VALEANT PHARMACEUTICALS INTE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.